Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ricerca Completes cGMP API Purification | Contract Pharma

What are you searching for?

Sign in
Breaking News

Ricerca Completes cGMP API Purification

Ricerca Biosciences has completed the purification of an active pharmaceutical ingredient (API) under cGMP controls.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ricerca Biosciences has completed the purification of an active pharmaceutical ingredient (API) under cGMP controls. The process involved chiral separation of a single API from three chiral isomers. More than 800 grams of material was processed to produce 525 grams of the desired isomer with >99.7% chiral purity and >99% achiral purity.

With the current configuration of the Prep HPLC system, the company is able to process as much as 1-2 kg of material under cGMP controls and the system is expandable to 6-8 kg capacity. It includes an automated fraction collection system to assist in the purification process.

“We are very pleased with the positive outcome of this purification process and the unique potential it has for our clients,” stated Michael Placke, senior vice president and general manager of the Concord, OH site. “This process marks a significant milestone for Ricerca as we continue to expand our capability in response to our client needs. We look forward to the results of this successful development.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters